Structured abstract information not available!
Structured Abstract Design: AMIS 2018 submitters are invited to prepare a written 'mini-pitch' of their research paper by using the 6 core elements of Faff’s (2017) template tool, with a maximum total of 250 words. These abstracts will appear in the AMIS conference booklet.
Prizes: The University of Queensland is sponsoring 3 prizes of €200 each for best written abstracts conforming to the mini-pitch design below.
|Idea?||Identify the 'core' idea that drives the intellectual content of this research topic. If appropriate:
|Data?||Make a brief statement about the data/sampling used in the study. For example:
|Tools?||State the basic empirical framework and research design. Is it a regression model approach? Survey instrument design? Interview design?
|What's New?||What is really new about your study? Briefly state (up to) three key findings of the study.
|So What?||Why is it important to know the answer? How will major decisions/behaviour/activity etc be influenced by the outcome of this research? What is the economic significance of the findings?
|Contribution?||What is the primary essence of the contribution to the relevant research literature?
DETERMINANTS OF CORPORATE R&D ACTIVITY IN POLAND: DOES THE PARTICIPATION OF SCIENTISTS ON THE BOARD MATTER?
Authors: Mrs. Anna Bialek-Jaworska, University of Warsaw, Poland
Mrs. Barbara Grabinska, Cracow University of Economics, Poland
Keywords: R&D; academic entrepreneurship; R&D subsidies; patents; internal finance
Idea: To examine the determinants of company R&D investment and verify the impact of academics participation within management or board of directors, taking into account financial constraints, subsidies and IP protection. To identify needs and barriers for the R&D outcomes commercialization by scientists engaging in business activity without university engagement as a shareholder.
Data: Panel data from annual reports of Polish private companies merged with data from the National Court Register (boards members), and data on patents and scientists employed at universities.
Tools: Tobit panel analysis based on a sample of 18,125 non-public Polish limited liability and joint-stock companies for 2003-2013.
What’s new: Three key findings: (1) Financial constraints are a more important limitation for R&D investments of companies with a scientist on their management. (2) Important sources of financing of R&D investment of companies with a scientist on their management or supervisory board are government subsidies for research and infrastructure. (3) Companies with scientists on the management and/or supervisory board with lower growth opportunities increase spending on commercializing their R&D outcomes.
So what: These findings could assist policymakers, investors, and scientists in effectively combining science with business in catching-up countries. They allow to learn the needs of companies established by scientists that are interested in commercialization of R&D outcomes.
Contribution: Identifying that companies with a scientist on their supervisory board are likelier to invest more in the R&D outcomes for commercialization. Private firms that conduct R&D activity resulting in patents are likelier to invest more in the R&D outcomes.
You can also download the above information in the document here
The following important dates also have to be taken into account: